AVEO PHARMACEUTICALS INC - COM NEW (AVEO) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2020 to Q1 2023

Type / Class
Equity / COM NEW
Symbol
AVEO
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AVEO PHARMACEUTICALS INC - COM NEW (AVEO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q1 0 $0 -$367,037,999 0
2022 Q4 24,551,313 $367,037,999 +$169,958,753 $14.95 108
2022 Q3 16,440,909 $135,304,372 +$7,921,242 $8.23 75
2022 Q2 15,415,018 $103,930,000 +$9,376,159 $6.56 52
2022 Q1 14,128,511 $81,753,000 -$5,543,197 $5.59 54
2021 Q4 15,421,793 $72,326,000 +$1,352,829 $4.69 51
2021 Q3 15,003,836 $95,868,000 +$3,486,905 $6.18 49
2021 Q2 14,289,573 $97,478,000 +$2,225,233 $6.59 58
2021 Q1 13,861,163 $105,071,000 +$24,894,808 $7.32 73
2020 Q4 10,473,548 $63,315,000 +$4,627,355 $5.77 59
2020 Q3 9,637,820 $60,204,000 -$7,626,503 $5.94 57
2020 Q2 11,123,382 $59,858,000 +$33,078,934 $5.15 60
2020 Q1 4,211,673 $69,362,000 +$15,242,000 $3.62 26